medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2009, Número 09-10

<< Anterior Siguiente >>

Medicina & Laboratorio 2009; 15 (09-10)


Pruebas de aliento basadas en hidrógeno

Campuzano MG

Idioma: Español
Referencias bibliográficas: 187
Paginas: 431-455
Archivo PDF: 1127.69 Kb.


RESUMEN

Las pruebas de aliento proporcionan una valiosa estrategia para evaluar in vivo una amplia variedad de actividades enzimáticas, las funciones de órganos y procesos de transporte. Las pruebas de aliento, tanto las que se basan en la medición de hidrógeno y metano, como las que utilizan isótopos estables como trazador son seguras, sin ninguna contraindicación, utilizables tanto en niños como en adultos, hombres y mujeres, aun estando embarazadas. En este módulo se describen los aspectos más importantes desde la clínica y del laboratorio clínico y su aplicación en la práctica médica como las pruebas de elección en el estudio de enfermedades digestivas relacionas con la malabsorción e intolerancia a carbohidratos, como la lactosa y la fructuosa, y el estudio del sobrecimientobacteriano, síndrome íntimamente relacionado con un sinnúmero de situaciones clínicas subyacentes. El conocimiento de las limitaciones de la prueba y los factores que influyen en los resultados son importantes para la correcta interpretación de los resultados de la prueba de aliento basadas en hidrógeno antes de sacar conclusiones clínicas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 1999; 729: 75-88.

  2. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta 2004; 347: 25-39.

  3. Cao W, Duan Y. Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem 2006; 52: 800-811.

  4. Campuzano-Maya G. Prueba de aliento con 13C-urea en el diagnóstico de Helicobacter pylori. Anales de la Academia de Medicina de Medellín 1999; 12: 25-37.

  5. Campuzano-Maya G. An optimized 13C-urea breath test for the diagnosis of H pylori infection. World J Gastroenterol 2007; 13: 5454-5464.

  6. Gasbarrini A, Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 2007; 25: 237-240.

  7. Hauser B, De Schepper J, Caveliers V, Salvatore S, Salvatoni A, Vandenplas Y. Variability of the 13C-octanoic acid breath test for gastric emptying of solids in healthy children. Aliment Pharmacol Ther 2006; 23: 1315-1319.

  8. Wutzke KD, Heine WE, Plath C, Leitzmann P, Radke M, Mohr C, et al. Evaluation of orocoecal transit time: a comparison of the lactose- [13C, 15N]ureide 13CO2- and the lactulose H2- breath test in humans. Eur J Clin Nutr 1997; 51: 11-19.

  9. Corazza GR, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology 1987; 93: 53-58.

  10. Lomer MC, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice--myths and realities. Aliment Pharmacol Ther 2008; 27: 93-103.

  11. Perman JA, Barr RG, Watkins JB. Sucrose malabsorption in children: noninvasive diagnosis by interval breath hydrogen determination. J Pediatr 1978; 93: 17-22.

  12. Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology 1983; 84: 26-29.

  13. Gudmand-Hoyer E, Krasilnikoff PA, Skovbjerg H. Sucrose-isomaltose malabsorption. Adv Nutr Res 1984; 6: 233-269.

  14. Dillon EL, Janghorbani M, Angel JA, Casperson SL, Grady JJ, Urban RJ, et al. Novel noninvasive breath test method for screening individuals at risk for diabetes. Diabetes Care 2009; 32: 430-435.

  15. Lewanczuk RZ, Paty BW, Toth EL. Comparison of the 13C-glucose breath test to the hyperinsulinemic- euglycemic clamp when determining insulin resistance. Diabetes Care 2004; 27: 441-447.

  16. Nakamura H, Morifuji M, Murakami Y, Uemura K, Ohge H, Hayashidani Y, et al. Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery. Surgery 2009; 145: 168-175.

  17. Ilan Y. Review article: the assessment of liver function using breath tests. Aliment Pharmacol Ther 2007; 26: 1293-1302.

  18. Petrolati A, Festi D, De Berardinis G, Colaiocco- Ferrante L, Di Paolo D, Tisone G, et al. 13Cmethacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 2003; 18: 785-790.

  19. Chladkova J, Havlinova Z, Chyba T, Krcmova I, Chladek J. Analysis of single-breath profiles of exhaled nitric oxide in children with allergy and asthma: guideline-derived plateau concentrations compared to results of automatic evaluation by two analyzers. J Asthma 2008; 45: 820-826.

  20. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009.

  21. Gessner C, Rechner B, Hammerschmidt S, Kuhn H, Hoheisel G, Sack U, et al. Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 2009.

  22. Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol 2008; 3: 774-780.

  23. Poli D, Goldoni M, Caglieri A, Ceresa G, Acampa O, Carbognani P, et al. Breath analysis in non small cell lung cancer patients after surgical tumour resection. Acta Biomed 2008; 79 Suppl 1: 64-72.

  24. Song G, Qin T, Liu H, Xu GB, Pan YY, Xiong FX, et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 2009.

  25. Levitt MD, Donaldson RM. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J Lab Clin Med 1970; 75: 937- 945.

  26. Newcomer AD, McGill DB, Thomas PJ, HofmannAF. Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med 1975; 293: 1232-1236.

  27. Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med 1975; 293: 524-526.

  28. Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med 1969; 281: 122-127.

  29. Olesen M, Rumessen JJ, Gudmand-Hoyer E. Intestinal transport and fermentation of resistant starch evaluated by the hydrogen breath test. Eur J Clin Nutr 1994; 48: 692-701.

  30. Wolin MJ. Fermentation in the rumen and human large intestine. Science 1981; 213: 1463-1468.

  31. Christl SU, Murgatroyd PR, Gibson GR, Cummings JH. Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 1992; 102: 1269-1277.

  32. Florin TH, Woods HJ. Inhibition of methanogenesis by human bile. Gut 1995; 37: 418-421.

  33. Vernia P, Camillo MD, Marinaro V, Caprilli R. Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients. Eur J Clin Nutr 2003; 57: 1116-1119.

  34. Levitt MD. Intestinal gas production. J Am Diet Assoc 1972; 60: 487-490.

  35. Steggerda FR. Gastrointestinal gas following food consumption. Ann N Y Acad Sci 1968; 150: 57- 66.

  36. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 Suppl 1: S147-171.

  37. Roberfroid MB, Bornet F, Bouley C, Cummings JH. Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev 1995; 53: 127-130.

  38. Solomons NW. Fermentation, fermented foods and lactose intolerance. Eur J Clin Nutr 2002; 56 Suppl 4: S50-55.

  39. Maldonado Celis ME. Intolerancia a la lactosa: causas moleculares, diagnóstico y consecuencias nutricionales. Medicina & Laboratorio 2000; 9: 461-479.

  40. Matthews SB, Waud JP, Roberts AG, Campbell AK. Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J 2005; 81: 167-173.

  41. Savilahti E, Launiala K, Kuitunen P. Congenital lactase deficiency. A clinical study on 16 patients. Arch Dis Child 1983; 58: 246-252.

  42. Lifshitz F. Congenital lactase deficiency. J Pediatr 1966; 69: 229-237.

  43. Hyams JS, Krause PJ, Gleason PA. Lactose malabsorption following rotavirus infection in young children. J Pediatr 1981; 99: 916-918.

  44. Swiatkowski E, Socha J. Lactose-intolerance and hypolactasia in children with giardiasis. J Pediatr Gastroenterol Nutr 1990; 11: 424-425.

  45. Thielman NM, Guerrant RL. Persistent diarrhea in the returned traveler. Infect Dis Clin North Am 1998; 12: 489-501.

  46. Ojetti V, Nucera G, Migneco A, Gabrielli M, Lauritano C, Danese S, et al. High prevalence of celiac disease in patients with lactose intolerance. Digestion 2005; 71: 106-110.

  47. Ojetti V, Gabrielli M, Migneco A, Lauritano C, Zocco MA, Scarpellini E, et al. Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet. Scand J Gastroenterol 2008; 43: 174-177.

  48. Castiglione F, Del Vecchio Blanco G, Rispo A, Petrelli G, Amalfi G, Cozzolino A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn’s disease. J Clin Gastroenterol 2000; 31: 63-66.

  49. Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz CC. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn’s Disease. BMC Gastroenterol 2009; 9: 61.

  50. Almeida JA, Kim R, Stoita A, McIver CJ, Kurtovic J, Riordan SM. Lactose malabsorption in the elderly: role of small intestinal bacterial overgrowth. Scand J Gastroenterol 2008; 43: 146- 154.

  51. Caspary WF. Diarrhoea associated with carbohydrate malabsorption. Clin Gastroenterol 1986; 15: 631-655.

  52. Hertzler SR, Savaiano DA. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr 1996; 64: 232-236.

  53. Gudmand-Hoyer E. The clinical significance of disaccharide maldigestion. Am J Clin Nutr 1994; 59: 735S-741S.

  54. Flatz G. Genetics of lactose digestion in humans. Adv Hum Genet 1987; 16: 1-77.

  55. Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol Suppl 1994; 202: 7-20.

  56. Aurisicchio LN, Pitchumoni CS. Lactose intolerance. Recognizing the link between diet and discomfort. Postgrad Med 1994; 95: 113-116, 119- 120.

  57. Ángel Arango LA, Calvo E, Muñoz Y. Prevalencia de hipolactasia tipo adulto e intolerancia a la lactosa en edultos jóvenes. Rev Col Gastroenterol 2005; 20: 35-47.

  58. Bayless TM, Rosensweig NS. A racial difference in incidence of lactase deficiency. A survey of milk intolerance and lactase deficiency in healthy adult males. JAMA 1966; 197: 968-972.

  59. McBean LD, Miller GD. Allaying fears and fallacies about lactose intolerance. J Am Diet Assoc 1998; 98: 671-676.

  60. Forget P, Lombet J, Grandfils C, Dandrifosse G, Geubelle F. Lactase insufficiency revisited. J Pediatr Gastroenterol Nutr 1985; 4: 868-872.

  61. Laroche M, Bon E, Moulinier L, Cantagrel A, Mazieres B. Lactose intolerance and osteoporosis in men. Rev Rhum Engl Ed 1995; 62: 766-769.

  62. Obermayer-Pietsch BM, Bonelli CM, Walter DE, Kuhn RJ, Fahrleitner-Pammer A, Berghold A, et al. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res 2004; 19: 42-47.

  63. Ángel LA, Araújo GE, Pérez M, Gutiérrez O, Castillo B. Prevalencia de hipolactasia tipo adulto, en biopsias de tercera porción de duodeno obtenidas por endoscopia en pacientes con indicación clínica de endoscopia digestiva alta. Acta Med Colomb 1999; 24: 41-48.

  64. Isokoski M, Jussila J, Sarna S. A simple screening method for lactose malabsorption. Gastroenterology 1972; 62: 28-32.

  65. Swagerty DL, Jr., Walling AD, Klein RM. Lactose intolerance. Am Fam Physician 2002; 65: 1845- 1850.

  66. Perman JA, Modler S, Olson AC. Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora. Studies in vivo and in vitro. J Clin Invest 1981; 67: 643-650.

  67. Hamilton LH. Protocol for lactose malabsorption. In: Hamilton LH, ed. Breath tests and gastroenterology(ed Second edition). Milwaukee: QuinTron Instruments Company; 1998: 33-36.

  68. Hamilton LH. Interpreting lactose malabsorption breath-tests. In: Hamilton LH, ed. Breath tests and gastroenterology (ed Second edition). Milwaukee: QuinTron Instruments Company; 1998: 37-47.

  69. Gilat T, Ben Hur H, Gelman-Malachi E, Terdiman R, Peled Y. Alterations of the colonic flora and their effect on the hydrogen breath test. Gut 1978; 19: 602-605.

  70. Thompson DG, Binfield P, De Belder A, O’Brien J, Warren S, Wilson M. Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut 1985; 26: 1349-1352.

  71. Mastropaolo G, Rees WD. Evaluation of the hydrogen breath test in man: definition and elimination of the early hydrogen peak. Gut 1987; 28: 721-725.

  72. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002; 97: 1113-1126.

  73. Acosta PB, Gross KC. Hidden sources of galactose in the environment. Eur J Pediatr 1995; 154: S87-92.

  74. Lieb J, Kazienko DJ. Lactose filler as a cause of “drug-induced” diarrhea. N Engl J Med 1978; 299: 314.

  75. Solomons NW, Torun B, Caballero B, Flores- Huerta S, Orozco G. The effect of dietary lactose on the early recovery from protein-energy malnutrition. I. Clinical and anthropometric indices. Am J Clin Nutr 1984; 40: 591-600.

  76. Filali A, Ben Hassine L, Dhouib H, Matri S, Ben Ammar A, Garoui H. [Study of malabsorption of lactose by the hydrogen breath test in a population of 70 Tunisian adults]. Gastroenterol Clin Biol 1987; 11: 554-557.

  77. Douwes AC, Schaap C, van der Klei-van Moorsel JM. Hydrogen breath test in schoolchildren. Arch Dis Child 1985; 60: 333-337.

  78. Roggero P, Offredi ML, Mosca F, Perazzani M, Mangiaterra V, Ghislanzoni P, et al. Lactose absorption and malabsorption in healthy Italian children: do the quantity of malabsorbed sugar and the small bowel transit time play roles in symptom production? J Pediatr Gastroenterol Nutr 1985; 4: 82-86.

  79. Le Marchand L, Wilkens LR, Harwood P, Cooney RV. Use of breath hydrogen and methane as markers of colonic fermentation in epidemiologic studies: circadian patterns of excretion. Environ Health Perspect 1992; 98: 199-202.

  80. Vogelsang H, Ferenci P, Frotz S, Meryn S, Gangl A. Acidic colonic microclimate--possible reason for false negative hydrogen breath tests. Gut 1988; 29: 21-26.

  81. Robb TA, Goodwin DA, Davidson GP. Faecal hydrogen production in vitro as an indicator for in vivo hydrogen producing capability in the breath hydrogen test. Acta Paediatr Scand 1985; 74: 942-944.

  82. Howell JN, Von der Fecht R, Flatz G. Hydrogen breath test for lactose tolerance adapted to population screening. Clin Chim Acta 1980; 103: 229-231.

  83. Vonk RJ, Lin Y, Koetse HA, Huang C, Zeng G, Elzinga H, et al. Lactose (mal)digestion evaluated by the 13C-lactose digestion test. Eur J Clin Invest 2000; 30: 140-146.

  84. Vonk RJ, Priebe MG, Koetse HA, Stellaard F, Lenoir-Wijnkoop I, Antoine JM, et al. Lactose intolerance: analysis of underlying factors. Eur J Clin Invest 2003; 33: 70-75.

  85. Mishkin D, Sablauskas L, Yalovsky M, Mishkin S. Fructose and sorbitol malabsorption in ambulatory patients with functional dyspepsia: comparison with lactose maldigestion/malabsorption. Dig Dis Sci 1997; 42: 2591-2598.

  86. Skoog SM, Bharucha AE. Dietary fructose and gastrointestinal symptoms: a review. Am J Gastroenterol 2004; 99: 2046-2050.

  87. Rumessen JJ. Fructose and related food carbohydrates. Sources, intake, absorption, and clinical implications. Scand J Gastroenterol 1992; 27: 819-828.

  88. Agriculture USDo. Agriculture Fact Book. 1998. Volume http://www.usda.gov/news/pubs/fbook98/ afb98.pdf.

  89. Gomara RE, Halata MS, Newman LJ, Bostwick HE, Berezin SH, Cukaj L, et al. Fructose intolerance in children presenting with abdominal pain. J Pediatr Gastroenterol Nutr 2008; 47: 303-308.

  90. Choi YK, Johlin FC, Jr., Summers RW, Jackson M, Rao SS. Fructose intolerance: an under-recognized problem. Am J Gastroenterol 2003; 98: 1348-1353.

  91. Yasawy MI, Folsch UR, Schmidt WE, Schwend M. Adult hereditary fructose intolerance. World J Gastroenterol 2009; 15: 2412-2413.

  92. Burmeister LA, Valdivia T, Nuttall FQ. Adult hereditary fructose intolerance. Arch Intern Med 1991; 151: 773-776.

  93. Cox TM. Iatrogenic deaths in hereditary fructose intolerance. Arch Dis Child 1993; 69: 413-415.

  94. Wenzel JJ, Rossmann H, Kullmer U, Oberman B, Mengel E, Lackner KJ, et al. Chronic diarrhea in a 5-year-old girl: pitfall in routine laboratory testing with potentially severe consequences. Clin Chem 2009; 55: 1026-1030; discussion 1030-1021.

  95. Hoekstra JH, van Kempen AA, Bijl SB, Kneepkens CM. Fructose breath hydrogen tests. Arch Dis Child 1993; 68: 136-138.

  96. Rao SS, Attaluri A, Anderson L, Stumbo P. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol 2007; 5: 959-963.

  97. Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 2008; 10: 160.

  98. Rumessen JJ, Gudmand-Hoyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986; 27: 1161-1168.

  99. Coss-Bu JA, Sunehag AL, Haymond MW. Contribution of galactose and fructose to glucose homeostasis. Metabolism 2009; 58: 1050-1058.

  100. Jain NK, Rosenberg DB, Ulahannan MJ, Glasser MJ, Pitchumoni CS. Sorbitol intolerance in adults. Am J Gastroenterol 1985; 80: 678-681. 101. Fernandez-Banares F, Esteve M, Viver JM. Fructose- sorbitol malabsorption. Curr Gastroenterol Rep 2009; 11: 368-374.

  101. Saad RJ, Chey WD. Breath tests for gastrointestinal disease: the real deal or just a lot of hot air? Gastroenterology 2007; 133: 1763-1766.

  102. Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 1986; 31: 147S-162S.

  103. Bouhnik Y, Alain S, Attar A, Flourie B, Raskine L, Sanson-Le Pors MJ, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94: 1327-1331.

  104. Toskes PP. Bacterial overgrowth of the gastrointestinal tract. Adv Intern Med 1993; 38: 387-407.

  105. Bauer TM, Steinbruckner B, Brinkmann FE, Ditzen AK, Schwacha H, Aponte JJ, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001; 96: 2962-2967.

  106. Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658-663.

  107. Dunn BE. Pathogenic mechanisms of Helicobacter pylori. Gastroenterol Clin North Am 1993; 22: 43- 57.

  108. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005; 51 Suppl 1: 1-22.

  109. Cater RE, 2nd. The clinical importance of hypochlorhydria (a consequence of chronic Helicobacter infection): its possible etiological role in mineral and amino acid malabsorption, depression, and other syndromes. Med Hypotheses 1992; 39: 375-383.

  110. McColl KE, el-Omar E, Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 2000; 29: 687-703, viii.

  111. Dobbs RJ, Dobbs SM, Weller C, Charlett A, Bjarnason IT, Curry A, et al. Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter 2008; 13: 309-322.

  112. Hutchinson S, Logan R. The effect of long-term omeprazole on the glucose-hydrogen breath test in elderly patients. Age Ageing 1997; 26: 87-89.

  113. Muscroft TJ, Deane SA, Youngs D, Burdon DW, Keighley MR. The microflora of the postoperative stomach. Br J Surg 1981; 68: 560-564.

  114. Browning GG, Buchan KA, Mackay C. The effect of vagotomy and drainage on the small bowel flora. Gut 1974; 15: 139-142.

  115. Greenlee HB, Vivit R, Paez J, Dietz A. Bacterial flora of the jejunum following peptic ulcer surgery. Arch Surg 1971; 102: 260-265.

  116. Roberts SH, James O, Jarvis EH. Bacterial overgrowth syndrome without “blind loop”: A cause for malnutrition in the elderly. Lancet 1977; 2: 1193-1195.

  117. Bird T, Hall MR, Schade RO. Gastric histology and its relation to anaemia in the elderly. Gerontology 1977; 23: 309-321.

  118. McEvoy A, Dutton J, James OF. Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. Br Med J (Clin Res Ed) 1983; 287: 789-793.

  119. Lewis SJ, Potts LF, Malhotra R, Mountford R. Small bowel bacterial overgrowth in subjects living in residential care homes. Age Ageing 1999; 28: 181-185.

  120. Gilman RH, Partanen R, Brown KH, Spira WM, Khanam S, Greenberg B, et al. Decreased gastric acid secretion and bacterial colonization of the stomach in severely malnourished Bangladeshi children. Gastroenterology 1988; 94: 1308- 1314.

  121. Stockbruegger RW, Cotton PB, Menon GG, Beilby JO, Bartholomew BA, Hill MJ, et al. Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol 1984; 19: 355-364.

  122. Chesner IM, Montgomery RD. Small bowel contamination and vitamin B12 deficiency in the elderly. J Clin Gastroenterol 1986; 8: 447-450.

  123. Henriksson AE, Blomquist L, Nord CE, Midtvedt T, Uribe A. Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Ann Rheum Dis 1993; 52: 503-510.

  124. Lauritano EC, Bilotta AL, Gabrielli M, Scarpellini E, Lupascu A, Laginestra A, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab 2007; 92: 4180-4184.

  125. Annese V, Bassotti G, Caruso N, De Cosmo S, Gabbrielli A, Modoni S, et al. Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 1999; 29: 171-177.

  126. Malagelada JR, Rees WD, Mazzotta LJ, Go VL. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology 1980; 78: 286-293.

  127. Resmini E, Parodi A, Savarino V, Greco A, Rebora A, Minuto F, et al. Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients. J Clin Endocrinol Metab 2007; 92: 2119-2124.

  128. Passaro E, Jr., Drenick E, Wilson SE. Bypass enteritis. A new complication of jejunoileal bypass for obesity. Am J Surg 1976; 131: 169-174.

  129. Justino SR, Goncalves Dias MC, Maculevicius J, Batista de Morais M, Sing TC, Halpern A, et al. Fasting breath hydrogen concentration in short bowel syndrome patients with colon incontinuity before and after antibiotic therapy. Nutrition 2004; 20: 187-191.

  130. Careskey JM, Weber TR, Grosfeld JL. Total colonic aganglionosis. Analysis of 16 cases. Am J Surg 1982; 143: 160-168.

  131. Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med 1981; 305: 1617-1627.

  132. Husebye E, Skar V, Hoverstad T, Iversen T, Melby K. Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology 1995; 109: 1078-1089.

  133. Milla PJ, Smith VV. Intestinal neuronal dysplasia. J Pediatr Gastroenterol Nutr 1993; 17: 356-357.

  134. Cohen J, Low P, Fealey R, Sheps S, Jiang NS. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol 1987; 22: 692-699.

  135. Nowak TV, Ionasescu V, Anuras S. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology 1982; 82: 800-810.

  136. Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci 2008; 53: 1163-1174.

  137. Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 2008; 6: 759-764.

  138. Parodi A, Sessarego M, Greco A, Bazzica M, Filaci G, Setti M, et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008; 103: 1257-1262.

  139. Oliveira RB, Meneghelli UG, de Godoy RA, Dantas RO, Padovan W. Abnormalities of interdigestive motility of the small intestine in patients with Chagas’ disease. Dig Dis Sci 1983; 28: 294-299.

  140. Chatila R, Kapadia CR. Intestinal pseudoobstruction in acute Lyme disease: a case report. Am J Gastroenterol 1998; 93: 1179-1180.

  141. Sonsino E, Mouy R, Foucaud P, Cezard JP, Aigrain Y, Bocquet L, et al. Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus. N Engl J Med 1984; 311: 196-197.

  142. Plotkin GR, Isselbacher KJ. Secondary disaccharidase deficiency in adult celiac disease (Nontropical sprue) and other malabsorption states. N Engl J Med 1964; 271: 1033-1037.

  143. Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol 2009; 43: 157-161.

  144. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004; 292: 852-858.

  145. Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004; 63: 450-452.

  146. Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Tana P, Corazza GR. Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating. Clin Gastroenterol Hepatol 2006; 4: 1242-1247.

  147. Lee HR, Pimentel M. Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth. Curr Gastroenterol Rep 2006; 8: 305-311.

  148. Pimentel M, Lezcano S. Irritable Bowel Syndrome: Bacterial Overgrowth--What’s Known and What to Do. Curr Treat Options Gastroenterol 2007; 10: 328-337.

  149. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-808.

  150. Carrara M, Desideri S, Azzurro M, Bulighin GM, Di Piramo D, Lomonaco L, et al. Small intestine bacterial overgrowth in patients with irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2008; 12: 197-202.

  151. Spiegel BM, Chey WD, Chang L. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors? Am J Gastroenterol 2008; 103: 2972-2976.

  152. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and metaanalysis. Clin Gastroenterol Hepatol 2009.

  153. Scarpellini E, Giorgio V, Gabrielli M, Lauritano EC, Pantanella A, Fundaro C, et al. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr 2009; 155: 416-420.

  154. Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology (Oxford) 2008; 47: 1223-1227.

  155. Logan AC, Beaulne TM. The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report. Altern Med Rev 2002; 7: 410-417.

  156. Weinstock LB, Fern SE, Duntley SP. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy. Dig Dis Sci 2008; 53: 1252- 1256.

  157. Hoffmann JC, Zeitz M. Small bowel disease in the elderly: diarrhoea and malabsorption. Best Pract Res Clin Gastroenterol 2002; 16: 17-36.

  158. Mendoza E, Crismatt C, Matos R, Sabagh O, Campo M, Cepeda J, et al. Diagnóstico de proliferación bacteriana intestinal en niños: evidencia experimental para sustentar el empleo de lactulosa en la prueba de hidrógeno y su validación como prueba tamiz. Biomédica 2007; 27: 325-332.

  159. Arrieche M, Hernández D, Olza M, Pestana E, Morera C, Jaen D. Sobrecrecimiento bacteriano en el intestino delgado: presentación clínica en la edad pediátrica. Colombia Médica 2005; 36: S58-S87.

  160. Sherman P, Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis 1987; 5: 157-171.

  161. De Boissieu D, Chaussain M, Badoual J, Raymond J, Dupont C. Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both. J Pediatr 1996; 128: 203-207.

  162. Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008; 43: 1030-1037.

  163. Mosekilde L, Melsen F, Hessov I, Christensen MS, Lund BJ, Lund BI, et al. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Gut 1980; 21: 624-631.

  164. Schulzke JD, Troger H, Amasheh M. Disorders of intestinal secretion and absorption. Best Pract Res Clin Gastroenterol 2009; 23: 395-406.

  165. Hasan M, Finucane P. Intestinal malabsorption presenting with night blindness. Br J Clin Pract 1993; 47: 275-276.

  166. Pitchon E, Sahli O, Borruat FX. Night blindness, yellow vision, and yellow skin: symptoms and signs of malabsorption. Klin Monatsbl Augenheilkd 2006; 223: 443-446.

  167. Aasheim ET, Sovik TT, Bakke EF. Night blindness after duodenal switch. Surg Obes Relat Dis 2008; 4: 685-686.

  168. Stotzer PO, Johansson C, Mellstrom D, Lindstedt G, Kilander AF. Bone mineral density in patientswith small intestinal bacterial overgrowth. Hepatogastroenterology 2003; 50: 1415-1418.

  169. Murphy MF, Sourial NA, Burman JF, Doyle DV, Tabaqchali S, Mollin DL. Megaloblastic anaemia due to vitamin B12 deficiency caused by small intestinal bacterial overgrowth: possible role of vitamin B12 analogues. Br J Haematol 1986; 62: 7-12.

  170. Bongaerts GP, Tolboom JJ, Naber AH, Sperl WJ, Severijnen RS, Bakkeren JA, et al. Role of bacteria in the pathogenesis of short bowel syndrome- associated D-lactic acidemia. Microb Pathog 1997; 22: 285-293.

  171. Giannella RA, Toskes PP. Gastrointestinal bleeding and iron absorption in the experimental blind loop syndrome. Am J Clin Nutr 1976; 29: 754- 757.

  172. Kohler H, McCormick BA, Walker WA. Bacterial- enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr 2003; 36: 175-185.

  173. Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 1967; 53: 845-855.

  174. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 2007; 44: 212-218.

  175. Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr 1999; 69: 354-365.

  176. Corazza GR, Menozzi MG, Strocchi A, Rasciti L,Vaira D, Lecchini R, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98: 302-309.

  177. Rumessen JJ, Gudmand-Hoyer E, Bachmann E, Justesen T. Diagnosis of bacterial overgrowth of the small intestine. Comparison of the 14C-D-xylose breath test and jejunal cultures in 60 patients. Scand J Gastroenterol 1985; 20: 1267-1275.

  178. Hamilton LH. Protocol for bacterial overgrowth. In: Hamilton LH, ed. Breath tests and gastroenterology (ed Second edition). Milwaukee: QuinTron Instruments Company; 1998: 54-56.

  179. Elphick DA, Chew TS, Higham SE, Bird N, Ahmad A, Sanders DS. Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier? Gerontology 2005; 51: 396-401.

  180. Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008; 53: 1443-1454.

  181. Kerckhoffs AP, Visser MR, Samsom M, van der Rest ME, de Vogel J, Harmsen W, et al. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol 2008; 42: 1095-1102.

  182. Abu-Shanab A, Quigley EM. Diagnosis of small intestinal bacterial overgrowth: the challenges persist! Expert Rev Gastroenterol Hepatol 2009; 3: 77-87.

  183. Perman JA, Modler S, Engel RR, Heldt G. Effect of ventilation on breath hydrogen measurements. J Lab Clin Med 1985; 105: 436-439.

  184. Strocchi A, Corazza G, Ellis CJ, Gasbarrini G, Levitt MD. Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria. Gastroenterology 1993; 105: 1404-1410.

  185. Dellert SF, Nowicki MJ, Farrell MK, Delente J, Heubi JE. The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr 1997; 25: 153- 158.

  186. Solomons NW, Schoeller DA, Wagonfeld JB, Ott D, Rosenberg IH, Klein PD. Application of a stable isotope (13C)-labeled glycocholate breath test to diagnosis of bacterial overgrowth and ileal dysfunction. J Lab Clin Med 1977; 90: 431-439.

  187. Klein PD. 13C breath tests: visions and realities. J Nutr 2001; 131: 1637S-1642S.




2020     |     www.medigraphic.com